Otc - Active Ingredient
Allantoin
Niacinamide
Gze Brightenng Exfoliating Gel
FDA Label NDC 74458-037
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Guangzhou Yilong Cosmetics Co., Ltd for the product Gze Brightenng Exfoliating Gel (NDC 74458-037). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, indications & usage, otc - purpose, warnings, otc - stop use, otc - do not use, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
Aqua
Butylene Glycol
Glycerin
Carbomer
Trehalose
Hydrolyzed Collagen
Aloe Barbadensis Leaf Extract
Hamamelis Virginiana (Witch Hazel) Extract
Centella Asiatica Extract
Phenoxyethanol
Ethylhexylglycerin
PEG-40 Hydrogenated Castor Oil
Fragrance
Indications & Usage
After cleansing face, take appropriateproducts
smear on the face. Along the skin texture and gently massagein circular
motions for 1-2 minutes, until thedead skin off the dirt.The rinse with water.
Otc - Purpose
Exfoliating.
Warnings
For external use only.
Otc - Stop Use
Stop use and ask a doctor if rash occurs.
Otc - Do Not Use
Do not use on damaged or broken skin.
Otc - When Using
When using this product keep out of eyes. Rinse with water to remove.
Otc - Keep Out Of Reach Of Children
1. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Dosage & Administration
After cleansing face, take appropriateproducts
smear on the face. Along the skin texture and gently massagein circular
motions for 1-2 minutes, until thedead skin off the dirt.The rinse with water.
Package Label.Principal Display Panel
Product Image (02)
* Please review the disclaimer below.
